New Key Statistics Module, Z-Score and F-Score
NAS:RARE Key Ratios
Market Cap $ M | 5,230.38 |
Enterprise Value $ M | 4,504.01 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 12.00 |
Price/Sales | 9.51 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 481.00 |
EPS (TTM) $ | -7.30 |
Beneish M-Score | -2.37 |
10-y EBITDA Growth Rate % | -14.30 |
5-y EBITDA Growth Rate % | -16.10 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -8.59 |
EV-to-EBITDA | -9.17 |
PEG | -- |
Shares Outstanding M | 92.17 |
Net Margin (%) | -121.57 |
Operating Margin % | -114.04 |
Pre-tax Margin (%) | -121.93 |
Quick Ratio | 3.39 |
Current Ratio | 3.54 |
ROA % (ttm) | -42.00 |
ROE % (ttm) | -290.00 |
ROIC % (ttm) | -75.33 |
Dividend Yield % | -- |
Altman Z-Score | -0.82 |
RARE Number of Guru Trades
RARE Volume of Guru Trades
Gurus Latest Trades with NAS:RARE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RARE is held by these investors
Total 1
Ultragenyx Pharmaceutical Inc Insider Transactions
No Available Data
News about NAS:RARE
Total 0- 1